Point-of-Care Tests for HIV Drug Resistance Monitoring: Advances and Potentials

Point-of-Care Tests for HIV Drug Resistance Monitoring: Advances and Potentials

HIV/AIDS is a global public health crisis that is yet to be contained. Effective management of HIV drug resistance (HIVDR) supported by close resistance monitoring is essential in achieving the WHO 95-95-95 targets, aiming to end the AIDS epidemic by 2030. Point-of-care tests (POCT) enable decentral...

Full description

Bibliographic Details
Main Authors:	Rayeil J. Chua, Rupert Capiña, Hezhao Ji
Format:	Article
Language:	English
Published:	MDPI AG 2022-06-01
Series:	Pathogens
Subjects:	HIV drug resistance point-of-care test resource-limited setting
Online Access:	https://www.mdpi.com/2076-0817/11/7/724

Similar Items

Point-of-Care Diagnostics for Improving Maternal Health in South Africa
by: Tivani P. Mashamba-Thompson, et al.
Published: (2016-08-01)

Characterizing HIV-1 Genetic Subtypes and Drug Resistance Mutations among Children, Adolescents and Pregnant Women in Sierra Leone
by: George A. Yendewa, et al.
Published: (2021-08-01)

Specification of implementation interventions to address the cascade of HIV care and treatment in resource-limited settings: a systematic review
by: Matthew D. Hickey, et al.
Published: (2017-08-01)

Overview of the Analytes Applied in Genotypic HIV Drug Resistance Testing
by: Hezhao Ji, et al.
Published: (2022-06-01)

HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies
by: Sontaga Manyana, et al.
Published: (2021-06-01)

A Scoping Review of Supply Chain Management Systems for Point of Care Diagnostic Services: Optimising COVID-19 Testing Capacity in Resource-Limited Settings
by: Kuhlula Maluleke, et al.
Published: (2021-12-01)

The Implementation of HIV Self-Testing in Resource-Limited Settings Where the HIV Disease Burden is High
by: Pachamuthu Balakrishnan, et al.
Published: (2023-05-01)

Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
by: Cheryl Jennings, et al.
Published: (2020-12-01)

Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings
by: Sontaga Manyana, et al.
Published: (2023-02-01)

Revolutionizing HIV-1 Viral Load Monitoring in India: The Potential of Dried Blood Spot Analysis for Expanding Access and Improving Care
by: Madhuri Chandane Tak, et al.
Published: (2024-02-01)

High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting
by: Patrick Kafui Akakpo, et al.
Published: (2023-05-01)

Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of PoC in Its Most Needed Environment
by: Benjamin Heidt, et al.
Published: (2020-09-01)

Evaluating HIV Rapid/Point of Care Testing among Risk Factor Groups in Ontario, 2011 to 2018
by: Heather Rilkoff, et al.
Published: (2023-01-01)

Drivers of retention of the HIV workforce transitioned from PEPFAR support to the Uganda government payroll
by: Henry Zakumumpa, et al.
Published: (2023-05-01)

Costs of Point-of-Care Viral Load Testing for Adults and Children Living with HIV in Kenya
by: Michelle Ann Bulterys, et al.
Published: (2021-01-01)

HIV-1 drug resistance genotyping success rates and correlates of Dried-blood spots and plasma specimen genotyping failure in a resource-limited setting
by: Jonah Omooja, et al.
Published: (2022-05-01)

Building clinical pharmacology laboratory capacity in low- and middle-income countries: Experience from Uganda
by: Denis Omali, et al.
Published: (2023-02-01)

Addressing Barriers to HIV Point-of-Care Testing in Community Pharmacies
by: Kimberly McKeirnan, et al.
Published: (2021-04-01)

Improving the Quality of Diagnostic Studies Evaluating Point of Care Tests for Acute HIV Infections: Problems and Recommendations
by: Megan Smallwood, et al.
Published: (2017-03-01)

Temporal discrepancies in “rapid” HIV testing: explaining misdiagnoses at the point-of-care in Zimbabwe
by: Morten Skovdal, et al.
Published: (2023-01-01)

External Quality Assessment Program for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Logistical Considerations
by: Hezhao Ji, et al.
Published: (2020-05-01)

Are We Ready for NGS HIV Drug Resistance Testing? The Second “Winnipeg Consensus” Symposium
by: Hezhao Ji, et al.
Published: (2020-05-01)

Pharmacists’ Opinions on the Implementation of HIV and HepC Point-of-Care-Testing in a U.S. Pharmacy Chain
by: Elizabeth So, et al.
Published: (2019-02-01)

External Quality Assessment for Next-Generation Sequencing-Based HIV Drug Resistance Testing: Unique Requirements and Challenges
by: Emma R. Lee, et al.
Published: (2020-05-01)

The path from a volunteer initiative to an established institution: evaluating 15 years of the development and contribution of the Lighthouse trust to the Malawian HIV response
by: Sam Phiri, et al.
Published: (2017-08-01)

Why does age at HIV infection correlate with set point viral load? An evolutionary hypothesis
by: Steven M. Goodreau, et al.
Published: (2022-12-01)

Optic nerve sheath diameter measurement using point-of-care ultrasound to assess intracranial pressure of adult patients with traumatic brain injury in resource-limited setting
by: Melaku Getachew, et al.
Published: (2023-12-01)

Socio-cultural representation of epilepsy at the teaching hospital of point G, Mali
by: Th Coulibaly, et al.
Published: (2023-12-01)

‘The baby will have the right beginning’: a qualitative study on mother and health worker views on point-of-care HIV birth testing across 10 sites in Zimbabwe
by: Emma Sacks, et al.
Published: (2022-09-01)

Development of Multiplexed Infectious Disease Lateral Flow Assays: Challenges and Opportunities
by: Khayriyyah Mohd Hanafiah, et al.
Published: (2017-09-01)

Dry Panels Supporting External Quality Assessment Programs for Next Generation Sequencing-Based HIV Drug Resistance Testing
by: Marc Noguera-Julian, et al.
Published: (2020-06-01)

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations
by: Santiago Ávila-Ríos, et al.
Published: (2020-06-01)

Establishing a Novel Diagnostic Framework Using Handheld Point-of-Care Focused-Echocardiography (HoPE) for Acute Left-Sided Cardiac Valve Emergencies: A Bayesian Approach for Emergency Physicians in Resource-Limited Settings
by: Kamlin Ekambaram, et al.
Published: (2023-08-01)

Quality Control of Next-Generation Sequencing-Based HIV-1 Drug Resistance Data in Clinical Laboratory Information Systems Framework
by: Rupert Capina, et al.
Published: (2020-06-01)

Precision Oncology by Point-of-Care Therapeutic Drug Monitoring and Dosage Adjustment of Conventional Cytotoxic Chemotherapies: A Perspective
by: Myriam Briki, et al.
Published: (2023-04-01)

Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy
by: Jienchi Dorward, et al.
Published: (2023-09-01)

The Impact of Early Antiretroviral Treatment (ART) for HIV on the Sensitivity of the Latest Generation of Blood Screening and Point of Care Assays
by: Marion Vermeulen, et al.
Published: (2022-06-01)

Point-of-care testing, new antiretroviral regimens and community-based treatment to enhance primary care HIV services in South Africa
by: Dorward, J
Published: (2022)

Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study
by: Deborah V. Kelly, et al.
Published: (2020-05-01)

Highly sensitive and rapid point-of-care testing for HIV-1 infection based on CRISPR-Cas13a system
by: Xiaohui Li, et al.
Published: (2023-09-01)